Combination therapy • Trial completion date • Trial primary completion date • Trial initiation date • Clinical
|
MSI (Microsatellite instability) • ICOS (Inducible T Cell Costimulator)
|
MSI-H/dMMR
|
VENTANA PD-L1 (SP263) Assay
|
Keytruda (pembrolizumab) • cisplatin • carboplatin • gemcitabine • paclitaxel • docetaxel • 5-fluorouracil • pemetrexed • Jemperli (dostarlimab-gxly) • bintrafusp alfa (M7824) • cobolimab (TSR-022) • feladilimab (GSK3359609) • GSK3174998